# Green Thumb Industries Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Green Thumb Industries Inc.). ## Overview Green Thumb Industries Inc. is a U.S.-based cannabis company that grows, processes, manufactures, distributes, and sells cannabis products through both branded consumer packaged goods and its own retail dispensaries. Founded in 2014 and headquartered in Chicago, it operates across 14 U.S. markets and combines cultivation, manufacturing, wholesale distribution, and retail under the RISE Dispensaries banner. ## Products & services • Cannabis flower and pre-rolls • Concentrates, vape products, capsules, tinctures • Edibles, topicals, and other cannabis SKUs • RISE Dispensaries retail cannabis stores • Branded CPG lines: &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, RYTHM - **Retail cannabis sales** (71%) — Sales of cannabis-related products through owned dispensaries, primarily under the RISE brand. - **Consumer Packaged Goods** (29%) — Branded cannabis products manufactured, distributed, and sold to third-party licensed retailers and company stores. - Cannabis flower and pre-rolls - Concentrates, vape products, capsules, tinctures - Edibles, topicals, and other cannabis SKUs - RISE Dispensaries retail cannabis stores - Branded CPG lines: &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, RYTHM ## Customers Green Thumb sells to two main customer groups: consumers and patients who shop its owned dispensaries, and licensed cannabis retailers that buy its branded products for resale. The company also serves adult-use and medical markets across its operating states, with demand shaped by local licensing, product availability, and state regulations. - **Retail dispensary consumers and patients** (primary) — Buy cannabis-related products at RISE and other stores for personal use, wellness, or medical needs. - **Licensed third-party cannabis retailers** (primary) — Purchase Green Thumb-branded products for resale in state-licensed dispensaries. - **Adult-use market customers** (secondary) — Buy products in states where recreational cannabis is legal, supporting store traffic and basket growth. - **Medical cannabis patients** (secondary) — Purchase regulated cannabis products for therapeutic use in medical programs. - Consumers and patients shopping at RISE Dispensaries - Licensed cannabis retailers buying branded products for resale - Adult-use customers in newly legalized or expanding states - Medical cannabis patients seeking regulated products - Buyers seeking branded flower, pre-rolls, edibles, and vapes ## Geography Green Thumb operates in 14 U.S. states, with revenue generated across California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, and Virginia. Its manufacturing footprint spans 13 states, while RISE dispensaries are present in all 14 markets, making state-level licensing and local regulation central to growth and operating flexibility. - **United States** (100%) — Revenue is generated entirely from U.S. operations across 14 states. - Operations span 14 U.S. states across major cannabis markets - RISE dispensaries operate in all 14 states where the company has revenue - Manufacturing and cultivation are spread across 13 states - State licensing drives store openings and market entry timing - Local cannabis rules affect sourcing, pricing, and margins ## Strategy Green Thumb’s strategy centers on combining owned retail with branded product manufacturing to capture value across the cannabis supply chain. Management is focused on sustainable profitable growth, expanding within existing markets, and adding stores or partnerships when licensing and capital conditions allow. - **Expand retail footprint in existing markets** (short-term) — More stores increase direct-to-consumer reach and improve control over merchandising and margins. - **Scale branded products through wholesale and retail channels** (medium-term) — Branded products create repeat demand and diversify revenue beyond store traffic. - **Maintain sustainable profitable growth** (medium-term) — Cannabis markets remain competitive and regulated, so disciplined growth is needed to protect returns. - Grow through both retail stores and branded product sales - Expand within existing states before entering new markets - Use RISE to control customer experience and shelf access - Leverage owned cultivation and manufacturing for supply control - Pursue acquisitions and partnerships where licensing permits ## Risks Green Thumb faces regulatory, competitive, and operating risks typical of the cannabis industry, including state-by-state licensing constraints, unfavorable U.S. tax treatment, and competition from lower-priced unregulated products. Its vertically integrated model also exposes it to cultivation, product quality, and retail execution risks, while the company’s early-stage industry context and concentrated voting control add governance and execution uncertainty. - **Regulatory and licensing constraints** [high] — Cannabis operations depend on state approvals, local permissions, and changing rules. - **Unfavorable tax treatment** [high] — Cannabis businesses may face significant tax burdens that compress margins and cash flow. - **Agricultural and cultivation risk** [medium] — The company grows cannabis, so pests, disease, climate control failures, and yield variability can affect supply. - **Product liability and recalls** [medium] — Cannabis products can trigger claims if quality, labeling, or safety issues arise. - **Competition from unregulated products** [high] — Untaxed or untested products can be priced lower than regulated cannabis. - State licensing limits store openings and market expansion - Cannabis tax rules can reduce after-tax profitability - Competition from unregulated products can pressure pricing - Cultivation exposes the business to crop and quality risks - Product liability, recalls, and consumer perception can hurt demand ## Accounting Key accounting issues include revenue recognition across retail and wholesale cannabis sales, inventory and cost allocation in a regulated agricultural business, and impairment testing for goodwill and intangibles. The company also has meaningful lease and debt accounting, while the 2025 sale of brand intellectual property and related licensing arrangements adds judgment around gains, ongoing license fees, and related-party investment accounting. - **Revenue recognition** — Affects reported revenue timing and comparability across periods - **Inventory costing and overhead allocation** — Affects gross profit and margin volatility - **Goodwill impairment** — Can create large non-cash charges - **Lease accounting** — Affects balance sheet leverage and operating expense presentation - **Brand intellectual property sale and licensing** — Affects other income, intangible assets, and future royalty/license expense - Retail and wholesale revenue recognition affects timing of reported sales - Inventory and overhead allocation influence gross margin in cultivation and manufacturing - Goodwill impairment depends on market and cash flow assumptions - Lease accounting matters for dispensaries and production facilities - Brand IP sale and licensing create judgment around gains and ongoing fees --- *Last updated: 2026-04-28T20:12:26.645326+00:00*